Indometacin Galvex (Indometacin)

Indometacin blocks the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin production, the drug diminishes the inflammatory response, thereby reducing pain, swelling and fever at the affected site.

The appropriate dose of Indometacin Galvex is determined by the prescribing healthcare professional based on the individual’s condition, severity, age, renal and hepatic function, and other concurrent medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of indometacin in pregnancy and lactation has not been definitively established. It is generally avoided during the third trimester because of potential fetal complications, and breastfeeding mothers should consult their physician, as the drug may pass into breast milk.

To request Indometacin Galvex, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indometacin is a potent NSAID with strong anti‑inflammatory activity, often considered more effective for gout and certain rheumatic conditions than some other NSAIDs. However, its gastrointestinal and renal risk profile may be higher, so clinicians balance efficacy against safety when selecting an NSAID for a patient.

Indometacin Galvex should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and sources of heat to maintain its stability and potency throughout its shelf life.

Indometacin Galvex is supplied as a rectal formulation. The prescribed dose is inserted into the rectum, usually using a pre‑filled applicator or suppository, following the healthcare provider’s instructions for proper placement and timing.

Serious risks include gastrointestinal ulceration or bleeding, severe renal impairment, hepatotoxicity, and rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored for signs of these events and seek immediate medical attention if they occur.

Indometacin Galvex is contraindicated in individuals with known hypersensitivity to indometacin or other NSAIDs, active gastrointestinal ulceration or bleeding, severe renal or hepatic impairment, and in the third trimester of pregnancy. Physicians should evaluate each patient’s medical history before prescribing.